Literature DB >> 2426114

Gamma globulin and methylprednisolone in idiopathic thrombocytopenic purpura.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2426114

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


× No keyword cloud information.
  7 in total

1.  High doses of gamma globulin and methylprednisolone therapy for idiopathic thrombocytopenic purpura in children.

Authors:  T Hara; S Miyazaki; N Yoshida; N Goya
Journal:  Eur J Pediatr       Date:  1985-09       Impact factor: 3.183

2.  High-dose intravenous gammaglobulin: a cautionary note.

Authors:  R Ljung; I M Nilsson
Journal:  Lancet       Date:  1985-02-23       Impact factor: 79.321

3.  Intravenous immunoglobulin for autoimmune thrombocytopenia of childhood.

Authors:  R W Walker; W Walker
Journal:  Lancet       Date:  1985-11-02       Impact factor: 79.321

4.  Vincristine for treatment of chronic thrombocytopenia in children.

Authors:  G Hicsönmez; S Ozsoylu
Journal:  N Engl J Med       Date:  1977-02-24       Impact factor: 91.245

5.  Bolus methylprednisolone therapy in chronic idiopathic thrombocytopenic purpura in children.

Authors:  S Ozsoylu
Journal:  Acta Haematol       Date:  1984       Impact factor: 2.195

6.  Treatment of acute idiopathic thrombocytopenia of childhood with intravenous infusions of gammaglobulin.

Authors:  J B Bussel; A Goldman; P Imbach; I Schulman; M W Hilgartner
Journal:  J Pediatr       Date:  1985-06       Impact factor: 4.406

7.  Intravenous immunoglobulin versus oral corticosteroids in acute immune thrombocytopenic purpura in childhood.

Authors:  P Imbach; H P Wagner; W Berchtold; G Gaedicke; A Hirt; P Joller; C Mueller-Eckhardt; B Müller; E Rossi; S Barandun
Journal:  Lancet       Date:  1985-08-31       Impact factor: 79.321

  7 in total
  2 in total

Review 1.  The nontreatment of childhood idiopathic thrombocytopenic purpura.

Authors:  G R Buchanan
Journal:  Eur J Pediatr       Date:  1987-03       Impact factor: 3.183

2.  High dose intravenous methylprednisolone for Kassabach-Merritt syndrome.

Authors:  S Ozsoylu; G Irken; A Gürgey
Journal:  Eur J Pediatr       Date:  1989-02       Impact factor: 3.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.